Lansoprazole Enteric Tablets and rabeprazole both belong to proton pump inhibitors, with slight differences in therapeutic effects and side effects, as follows: 1. Therapeutic effects: The clinical effects of lansoprazole for reflux esophagitis are better than omeprazole, the pressure of rabeprazole to relieve patients’ abdominal pain is better than omeprazole, and the inhibition of Helicobacter pylori is stronger than omeprazole and lansoprazole. 2. Side effects: Lansoprazole’s side effects will be diarrhea, headache and skin reactions, and the side effects of rabeprazole are relatively mild. Proton pump inhibitors are the most advanced class of drugs for the treatment of peptic ulcers, which achieve a rapid cure for ulcers by efficiently and rapidly inhibiting gastric acid secretion and removing Helicobacter pylori. There are three generations commonly used, the first generation is omeprazole, the second generation is lansoprazole, the third generation is pantoprazole, rabeprazole and esomeprazole, the five drugs are roughly the same clinical application, but there are major differences in adverse reactions and effects, to distinguish the choice according to the patient’s condition.